XML 104 R30.htm IDEA: XBRL DOCUMENT
v3.26.1

Description of the Business (Details) $ / shares in Units, $ in Thousands |  |  |  |  |  | 1 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Mar. 18, 2026 USD ($) $ / shares shares | Mar. 17, 2026 USD ($) shares | Nov. 17, 2025 USD ($) $ / shares shares | Oct. 21, 2025 USD ($) shares | Feb. 06, 2024 USD ($) $ / shares shares | Mar. 31, 2026 USD ($) subsidiary clinical-stageAsset $ / shares shares | Oct. 31, 2025 $ / shares shares | Feb. 29, 2024 shares | Dec. 31, 2025 USD ($)
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Number of wholly owned subsidiaries | subsidiary |  |  |  |  |  | 1 |  |  |
Number of clinical-stage assets | clinical-stageAsset |  |  |  |  |  | 7 |  |  |
Accumulated deficit | $ |  |  |  |  |  | $ 227,871 |  |  | $ 201,634
Preferred stock conversion, number of common stock (in shares) |  |  |  |  |  |  |  | 13,664,261 |
IPO |  |  |  |  |  |  |  |  |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, number of shares issued in transaction (in shares) |  |  |  |  | 9,246,000 |  |  |  |
Sale of stock, price per share (in dollars per share) | $ / shares |  |  |  |  | $ 16.00 |  |  |  |
Sale of stock, consideration received on transaction | $ |  |  |  |  | $ 133,000 |  |  |  |
Number of shares called by warrants (in shares) |  |  |  |  | 72,631 |  |  |  |
Over-Allotment Option |  |  |  |  |  |  |  |  |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, number of shares issued in transaction (in shares) |  |  |  |  | 1,206,000 |  |  |  |
Private Placement |  |  |  |  |  |  |  |  |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, number of shares issued in transaction (in shares) |  | 2,900,000 |  | 3,832,263 |  | 2,900,000 | 3,832,263 |  |
Sale of stock, price per share (in dollars per share) | $ / shares |  |  |  |  |  | $ 20.00 | $ 5.9140 |  |
Sale of stock, consideration received on transaction | $ |  | $ 114,900 |  | $ 49,700 |  |  |  |  |
Number of shares called by warrants (in shares) |  |  |  |  |  |  | 4,622,251 |  |
Pre-Funded Warrants |  |  |  |  |  |  |  |  |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Number of shares called by warrants (in shares) |  | 3,100,000 |  | 4,622,251 |  | 3,100,000 |  |  |
K2 Healthventures LLC |  |  |  |  |  |  |  |  |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, price per share (in dollars per share) | $ / shares | $ 4.83 |  | $ 4.83 |  |  |  |  |  |
Sale of stock conversion of outstanding loan | $ | $ 1,000 |  | $ 4,000 |  |  |  |  |  |
Stock issued during period (in shares) | 207,215 |  | 828,860 |  |  |  |  |  |

X
- Definition Number Of Clinical-Stage Assets + References No definition available. + Details
Name: | alto_NumberOfClinicalStageAssets
Namespace Prefix: | alto_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of Wholly Owned Subsidiaries + References No definition available. + Details
Name: | alto_NumberOfWhollyOwnedSubsidiaries
Namespace Prefix: | alto_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Sale Of Stock, Conversion Of Outstanding Loan + References No definition available. + Details
Name: | alto_SaleOfStockConversionOfOutstandingLoan
Namespace Prefix: | alto_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Temporary Equity, Shares, Conversion Of Convertible Securities + References No definition available. + Details
Name: | alto_TemporaryEquitySharesConversionOfConvertibleSecurities
Namespace Prefix: | alto_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of accumulated undistributed earnings (deficit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of stock issued attributable to transactions classified as other. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=alto_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=alto_K2HealthventuresLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |